Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd. – Trademark Portfolio
Entity Type: 99
Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include EQUORVETA. The owner is based in Guilin City.
Room 1-3-2, No. 1 Building, Shangzhu Building, No. 7 Kangzhan Road, Diecai District
Guilin City Guangxi Zhuang Autonomous Region
Guilin City 541000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd. have?
Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd. file in?
Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd.'s most well-known trademarks?
Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as EQUORVETA. These are among 1 currently registered trademark in the portfolio.
What is Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd.'s trademark registration success rate?
Guangxi Guilin Wan Chen Yuan Qi Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.